SCHEMBL30007734

SCHEMBL30007734

CC(C)S(=O)(=O)c1ccc(-c2cnc3[nH]cc(C(=O)Nc4ccc(N(C)C)cc4)c3c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 1/20 0.45
MAPK9 P45984 1/20 0.45
MAPK10 P53779 1/20 0.45
CLK1 P49759 3/20 0.43
DYRK1A Q13627 3/20 0.43
DYRK2 Q92630 3/20 0.43
DYRK1B Q9Y463 3/20 0.43
PIK3CA P42336 1/20 0.43
AXL P30530 2/20 0.42
BRAF P15056 3/20 0.42
PIK3CG P48736 1/20 0.42
ATR Q13535 2/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
USP28 Q96RU2 1/20 0.40
PRKDC P78527 1/20 0.40
ATM Q13315 1/20 0.40
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL30007576 0.81 AXL (0.54) DYRK1APIK3CAAXLPIK3CGCAMKK2
SCHEMBL30008206 0.80 CLK1 (0.43) CLK1DYRK1AAXLBRAFATR
SCHEMBL30008314 0.79 AXL (0.67) DYRK1APIK3CAAXLCAMKK2
SCHEMBL30007677 0.77 AXL (0.50) MAPK9PIK3CAAXLMAP3K11CAMKK2
SCHEMBL13854175 0.73 MAPK8 (0.50) MAPK8MAPK9MAPK10AXLBRAF
SCHEMBL14616599 0.72 ATR (0.52) ATRMEN1KMT2APRKDCATM
SCHEMBL30007804 0.72 ALDH1A1 (0.46) AXLBRAFCYP3A4MAP3K11
SCHEMBL27984171 0.71 MAPK8 (0.47) MAPK8MAPK9MAPK10AXLBRAF
SCHEMBL14575295 0.71 ATR (0.52) CLK1DYRK1AATRPRKDCATM
SCHEMBL14575030 0.71 ATR (0.56) ATRPRKDCATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022237922-A1 ANTITUMOR COMPOUNDS BASED ON NITROGEN HETEROCYCLES AND USE THEREOF AS MEDICAMENTS FAKULTNI NEMOCNICE HRADEC KRALOVE (CZ) 2022-11-17 WO claimed
WO-2022237922-A1 ANTITUMOR COMPOUNDS BASED ON NITROGEN HETEROCYCLES AND USE THEREOF AS MEDICAMENTS FAKULTNI NEMOCNICE HRADEC KRALOVE (CZ) 2022-11-17 WO disclosed